ASCP, Lab Community Urge Increased Funding for Variant Identification
In a letter to Congressional leadership, ASCP and other organizations are calling for more federal funding to support a Centers for Disease Control and Prevention program that would enhance the agency’s surveillance capabilities for the coronavirus. Read
more.
ASCP Helps Deflect Cuts to Medicare Reimbursement Rates
Working with the American Medical Association and other medical societies, ASCP helped prevent the imposition of a two-percent “sequester cut” to the Medicare program. The cuts would have affected the Medicare physician and clinical laboratory fee schedules. Read
more.
Advocating for Patients with Long COVID
In the spirit of StrongerTogether, ASCP is working with the American Academy of Physical Medicine and Rehabilitation to ensure all patients experiencing post-acute sequelae of SARS-CoV-2 infection are able to access the care they need. Read
more.
U.S. Preventive Services Task Force Recognizes ASCP Vitamin D Recommendations
Citing ASCP’s recent recommendation on vitamin D screening, the U.S. Preventive Services Task Force has determined there is not “enough evidence to recommend the general population be screened for vitamin D deficiency.” Read
more.
At-Homes COVID Tests Require Appropriate Guidance
ASCP has asked the Food and Drug Administration to ensure when COVID-19 tests are approved for at-home use that users are provided appropriate guidance on test use and interpretation. Read
more.
For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.
ASCP ePolicy News is supported by an unrestricted grant from Hologic.